PFIZER, INC.

PFE
Delayed Quote. Delayed  - 07/01 04:03:09 pm
52.31USD -0.23%

Turn to zoom
Prev.52.3100
Open52.0400
High52.3700
Low51.2500
Volume16 135 661
Latest news
1d ago
1d ago
2d ago
2d ago
Chart PFIZER, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance54,059,159,5
Spread/Res.-3,1%-11%-12%
Spread/Supp.14%14%26%
Support45,845,841,5
Financials
Sales 2022 104 B - -
Net income 2022 35 924 M - -
Net cash 2022 12 888 M - -
P/E ratio 2022 8,70x
Yield 2022 3,10%
Capitalization 294 B 294 B -
EV / Sales 2022 2,70x
EV / Sales 2023 3,42x
Nbr of Employees 79 000
Free-Float 59,0%
Company
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- vaccines (52.4%);
- drugs for the treatment of cancer (15.2%);
- cardiovascular, metabolic and analgesic drugs (11.5%);
- injectable, anti-infectives drugs and active pharmaceutical...
Sector :
Other Pharmaceuticals
Calendar :
2022-07-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 52,31 $
Average target price 57,00 $
Spread / Average Target 8,97%